Site icon Autoimmune Encephalitis

AE Speaker Series February-2021

AE awareness Month Holographic Logo_Celia Fermon

AE  Awareness Month

Speakers Series Announced

In Celebration of Autoimmune Encephalitis Month- February 2021, we are pleased to be providing the AE community with a range of speakers who will be providing live presentations that can be viewed by IAES members at a later date for those unable to attend.

Eoin Flanagan, M.B., B.CH.

Mayo Clinic

Autoimmune Encephalitis

Recorded February 2nd, 2021


Dr. Flanagan’s clinical expertise and research are focused on the diagnosis and management of autoimmune neurological disorders with an emphasis on inflammatory autoimmune spinal cord disorders and their mimics including their MRI patterns. He also has an interest in the epidemiology of inflammatory demyelinating diseases of the central nervous system and autoimmune neurologic disorders.

Justin Abbatemarco, MD

University of Utah Autoimmune Neurology

AE Treatments & Long Term Management

Recorded February 3rd, 2021


Dr. Abbatemarco is currently at the University of Utah in Salt Lake City completing his fellowship in Autoimmune Neurology and will be joining the faculty at the Cleveland Clinic in July 2021, where he had previously completed his neuroimmunology fellowship at the Cleveland Clinic Mellen Center for Multiple Sclerosis Treatment and Research. He has an interest in a wide spectrum of autoimmune neurological disorders with active research in multiple sclerosis and autoimmune encephalitis.

Belinda Lennox, BM BS MRCPsych DM

DM FRCPSYCH, Professor of Psychiatry At Oxford NeuroScience and Honorary Consultant Psychiatrist in the Early Intervention in Psychosis service for Oxford Health NHS Foundation Trust.

Autoimmune Psychosis

February 9th, 2021


Dr. Lennox’s interests are in discovering the causes of and developing more effective treatments for people with psychosis, and in implementing those discoveries into clinical practice. She runs a clinic, jointly with neuroimmunologists, for patients with neuronal cell surface antibodies and is currently running a double-blind randomized controlled trial of intravenous immunoglobulin and rituximab in patients with psychosis and antibodies (the SINAPPS2 trial). Please submit any questions you have for Dr. Lennox on the registration form.

Antibody-mediated Psychosis Resources for the Public

Stefanie J. Rodenbeck, MD

Neuroimmunology ~ University of Utah

Autoimmune Epilepsy

February 12th, 1 PM EST


 Dr. Rodenbeck is currently at the University of Utah in Salt Lake City completing her fellowship in Autoimmune Neurology and will be joining the faculty at the University of Indiana in July 2021.  Dr. Rodenbeck’s most recent clinical and research experiences focused on autoimmune and paraneoplastic encephalitis. 

Autoimmune Epilepsy is a frequent topic among the AE community and Dr. Rodenbeck is excited to have the opportunity to help us understand the condition more clearly and answer questions you would like to have addressed. Please submit any questions you have for Dr. Rodenbeck on the registration form. 

Michael Sweeney, MD

Pediatric Neurologist ~ University of Louisville

Pediatric AE

February 26th, 2 PM EST


Assistant Professor in the Division of Child Neurology at the University of Louisville, Kentucky will be presenting on Pediatric Autoimmune Encephalitis. He was the first pediatric neurologist to complete an autoimmune neurology fellowship at the University of Utah. Upon joining as faculty at the University of Louisville in 2016, he started the region’s first-ever clinic to treat children specifically with immune-mediated neurologic disorders. He also joined with colleagues in the Department of Neurology to start an adult autoimmune neurology clinic in conjunction with an established neuroimmunology program. Please submit any questions you may have for Dr. Sweeney on your registration form. 

Exit mobile version